DOSSIER · 13F Holders · Q2 2026
CPHI

CHINA PHARMA HLDGS INC

8 institutions still hold CHINA PHARMA HLDGS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 16941T401·8 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$125K
visible holders
Holders
8
filers reporting
Concentration
66.05%
CITADEL ADVISORS LLC #1
top holder share
AI Holders Summary · Q2 2026

8 institutions reported CPHI in Q2 2026. CITADEL ADVISORS LLC leads at 66.1% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
CITADEL ADVISORS LLC
CIK 0001423053
$83K125K0.00%Q2 2026
02
TWO SIGMA SECURITIES, LLC
CIK 0001450144· Market maker
$24K36K0.00%Q2 2026
03
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
$10K15K0.00%Q2 2026
04
Ground Swell Capital, LLC
CIK 0001534450
$7K11K0.01%Q2 2026
05
UBS Group AG
CIK 0001610520
$2K3K0.00%Q2 2026
06
EFG International AG
CIK 0002109868
$26400.00%Q2 2026
07
DANSKE BANK A/S
CIK 0000800177
$110.00%Q2 2026
08
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00Q2 2025
Insiders at CHINA PHARMA HLDGS INC
Li ZhilinWaung Frank